New technology shows high transfection efficiencies in mammalian cells without the kill effect associated with electroporation or the problems from chemical or viral methods
IPBio has introduced what it says is a unique and groundbreaking technology for improved efficiency transfection - called ImmunoPoration.
ImmunoPoration shows extremely high transfection efficiencies in mammalian cells without either the kill effect associated with electroporation or the toxic or bio problems from chemical or viral methods.
ImmunoPoration has other more important features with its unique cell attachment design, by choosing either the generic kit to 'transfect most cells' or the antibody specific kits to directly select transfection to your 'chosen cell type' in a heterogeneous sample.
These advantages add major significance not just in pure life science research but also within cell engineering or gene therapy markets where cell specific transfection is crucial.
The technology is based on antibody attached magnetic beads making ImmunoPoration extremely easy to use, and only requiring a magnetic rack and mixer also available from IPBio.
